{
  "run": {
    "id": "cmnr0l45x01pap658lqttxmnl",
    "region": "US",
    "assetId": "cmnr0l45e01p6p658z9mxe7cf",
    "ticker": "AFL",
    "snapshotId": "cmnr0l45m01p8p658nkm7run6",
    "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux",
    "createdAt": "2026-04-09T05:06:15.762Z",
    "promptTemplate": {
      "id": "cmnqt07si0005lm3jzpxuu1ux",
      "name": "Oficial 08.apr.2026",
      "version": 1
    },
    "snapshot": {
      "id": "cmnr0l45m01p8p658nkm7run6",
      "assetId": "cmnr0l45e01p6p658z9mxe7cf",
      "asOf": "2026-04-08T20:00:02.000Z",
      "snapshot": {
        "asOf": "2026-04-08T20:00:02.000Z",
        "quote": {
          "asOf": "2026-04-08T20:00:02.000Z",
          "open": null,
          "price": 113,
          "dayLow": 109.73,
          "volume": 1610473,
          "dayHigh": 113.005,
          "currency": "USD",
          "prevClose": 110.52,
          "week52Low": 96.95,
          "week52High": 119.32
        },
        "fundamentals": {
          "pe": 16.1213450292398,
          "beta": 0.601769589742776,
          "epsTTM": 6.84,
          "fcfTTM": 2555000000,
          "growth": {
            "epsYoy": -0.2933884297520661,
            "revenueYoy": -0.09314735562952396
          },
          "sector": "Accident & Health Insurance",
          "margins": {
            "net": 0.2124213470053601,
            "gross": null,
            "operating": 0.2004194826380797
          },
          "website": "http://aflac.com",
          "industry": "Insurance",
          "pegRatio": -0.549488098179722,
          "ebitdaTTM": 5064000000,
          "forwardPe": 15.0642076502732,
          "marketCap": 56035389963,
          "totalCash": 6245000000,
          "totalDebt": 700000000,
          "debtEquity": 0.02373685995252628,
          "quickRatio": null,
          "revenueTTM": 17164000000,
          "companyName": "AFLAC INC",
          "priceToBook": 1.99258151746355,
          "currentRatio": null,
          "dividendYield": 0.0211193676881055,
          "returnOnAssets": 0.03130419850605306,
          "returnOnEquity": 0.12363513055273,
          "analystOpinions": null,
          "businessSummary": "Aflac Incorporated /ˈæflæk/ (American Family Life Assurance Company) is an American insurance company and is the largest provider of supplemental insurance in the United States. It was founded in 1955 and is based in Columbus, Georgia. In the U.S., it underwrites a wide range of insurance policies, but is perhaps more known for its payroll deduction insurance coverage, which pays cash benefits when a policyholder has a covered accident or illness. The company states it \"provides financial protection to more than 50 million people worldwide\".",
          "enterpriseValue": null,
          "analystTargetLow": null,
          "analystTargetHigh": null,
          "analystTargetMean": null,
          "fullTimeEmployees": 12694,
          "sharesOutstanding": 516369452,
          "enterpriseToEbitda": null,
          "analystTargetMedian": null,
          "enterpriseToRevenue": null,
          "operatingCashflowTTM": 2555000000,
          "analystRecommendationKey": null
        }
      },
      "createdAt": "2026-04-09T05:06:15.754Z"
    },
    "results": [
      {
        "id": "cmnr0l45z01pcp658sqfgr6dd",
        "runId": "cmnr0l45x01pap658lqttxmnl",
        "modelId": "anthropic",
        "status": "SUCCESS",
        "rawOutput": "{\"model\":\"ai-equity-research-v1\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"AFL\",\"currency\":\"USD\",\"current_price\":113,\"target_price_6m\":116,\"target_price_12m\":118,\"recommendation\":\"HOLD\",\"confidence\":0.58,\"thesis_bullets\":[\"Mature supplemental insurer with dominant US/Japan franchise and low leverage\",\"EPS declined 29% YoY and revenue fell 9%, signaling near-term headwinds\",\"Forward P/E of 15x implies modest earnings recovery already priced in\",\"Very low debt/equity (0.024) and strong FCF support buybacks and dividends\",\"Valuation near fair value at ~16x TTM earnings limits upside from here\"],\"key_drivers\":[{\"driver\":\"Japan segment premium trends and yen FX translation\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"US supplemental insurance sales growth trajectory\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Share repurchase program reducing float\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Investment portfolio yield and unrealized gains/losses\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Dividend growth track record (42 consecutive years)\",\"impact\":\"LOW\",\"direction\":\"POS\"},{\"driver\":\"Expense management and operating margin stability\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Interest rate environment impact on fixed income portfolio\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Regulatory changes in Japan insurance market\",\"impact\":\"LOW\",\"direction\":\"NEG\"}],\"risks\":[\"Continued yen depreciation eroding Japan segment earnings on translation\",\"Sustained EPS decline if claims experience worsens or sales stagnate\",\"Investment portfolio losses from credit spreads widening or rate volatility\",\"Japan demographic headwinds reducing long-term policyholder base\",\"Potential US regulatory changes affecting supplemental insurance products\"],\"assumptions\":{\"revenue_cagr_3y\":0.02,\"ebit_margin_target\":0.13,\"wacc\":0.085,\"terminal_multiple\":15.5},\"scenarios\":{\"bear\":{\"target_price\":98,\"prob\":0.2,\"notes\":\"Continued earnings deterioration, yen weakness, claims spike; P/E compresses to 13x.\"},\"base\":{\"target_price\":118,\"prob\":0.55,\"notes\":\"Modest EPS recovery to ~$7.50, stable P/E of ~15.5x; dividends and buybacks support.\"},\"bull\":{\"target_price\":135,\"prob\":0.25,\"notes\":\"Strong earnings rebound, yen stabilization, accelerating US sales; P/E re-rates to 17x.\"}},\"method_notes\":\"Earnings-power valuation anchored on forward EPS (~$7.50 implied by forward P/E) and a fair P/E range of 14-17x for a low-beta insurer. 12M base target of $118 implies ~4.4% price return + ~2.1% dividend = ~6.5% total return, but price-only return of 4.4% falls in HOLD band given mixed signals (declining YoY EPS/revenue vs low leverage and buyback support). Revenue_cagr_3y = premium growth; ebit_margin_target = ROE anchor; wacc = cost of equity; terminal_multiple = normalized P/E. Not investment advice.\"}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "ai-equity-research-v1",
          "risks": [
            "Continued yen depreciation eroding Japan segment earnings on translation",
            "Sustained EPS decline if claims experience worsens or sales stagnate",
            "Investment portfolio losses from credit spreads widening or rate volatility",
            "Japan demographic headwinds reducing long-term policyholder base",
            "Potential US regulatory changes affecting supplemental insurance products"
          ],
          "ticker": "AFL",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.55,
              "notes": "Modest EPS recovery to ~$7.50, stable P/E of ~15.5x; dividends and buybacks support.",
              "target_price": 118
            },
            "bear": {
              "prob": 0.2,
              "notes": "Continued earnings deterioration, yen weakness, claims spike; P/E compresses to 13x.",
              "target_price": 98
            },
            "bull": {
              "prob": 0.25,
              "notes": "Strong earnings rebound, yen stabilization, accelerating US sales; P/E re-rates to 17x.",
              "target_price": 135
            }
          },
          "confidence": 0.58,
          "assumptions": {
            "wacc": 0.085,
            "revenue_cagr_3y": 0.02,
            "terminal_multiple": 15.5,
            "ebit_margin_target": 0.13
          },
          "key_drivers": [
            {
              "driver": "Japan segment premium trends and yen FX translation",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "US supplemental insurance sales growth trajectory",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Share repurchase program reducing float",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Investment portfolio yield and unrealized gains/losses",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Dividend growth track record (42 consecutive years)",
              "impact": "LOW",
              "direction": "POS"
            },
            {
              "driver": "Expense management and operating margin stability",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Interest rate environment impact on fixed income portfolio",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Regulatory changes in Japan insurance market",
              "impact": "LOW",
              "direction": "NEG"
            }
          ],
          "method_notes": "Earnings-power valuation anchored on forward EPS (~$7.50 implied by forward P/E) and a fair P/E range of 14-17x for a low-beta insurer. 12M base target of $118 implies ~4.4% price return + ~2.1% dividend = ~6.5% total return, but price-only return of 4.4% falls in HOLD band given mixed signals (declining YoY EPS/revenue vs low leverage and buyback support). Revenue_cagr_3y = premium growth; ebit_margin_target = ROE anchor; wacc = cost of equity; terminal_multiple = normalized P/E. Not investment advice.",
          "current_price": 113,
          "recommendation": "HOLD",
          "thesis_bullets": [
            "Mature supplemental insurer with dominant US/Japan franchise and low leverage",
            "EPS declined 29% YoY and revenue fell 9%, signaling near-term headwinds",
            "Forward P/E of 15x implies modest earnings recovery already priced in",
            "Very low debt/equity (0.024) and strong FCF support buybacks and dividends",
            "Valuation near fair value at ~16x TTM earnings limits upside from here"
          ],
          "target_price_6m": 116,
          "target_price_12m": 118
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "anthropic",
            "webSearch": {
              "enabled": false,
              "maxToolCalls": 2,
              "disabledReason": null
            },
            "pauseTurns": 0,
            "stopReason": "end_turn"
          },
          "sanityIssues": []
        },
        "latencyMs": 48677,
        "createdAt": "2026-04-09T05:06:15.762Z",
        "usage": {
          "inputTokens": 3594,
          "outputTokens": 2074,
          "costUsd": 0.06982
        }
      },
      {
        "id": "cmnr0l45z01pfp6580o7xpj6q",
        "runId": "cmnr0l45x01pap658lqttxmnl",
        "modelId": "deepseek.reasoner",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"Insurance_DCF_Multiples\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"AFL\",\n  \"currency\": \"USD\",\n  \"current_price\": 113,\n  \"target_price_6m\": 114,\n  \"target_price_12m\": 115,\n  \"recommendation\": \"HOLD\",\n  \"confidence\": 0.6,\n  \"thesis_bullets\": [\n    \"Stable demand for supplemental insurance products.\",\n    \"Recent negative revenue and EPS growth due to headwinds.\",\n    \"Strong balance sheet with low debt enhances resilience.\",\n    \"Dividend yield provides income but growth is uncertain.\",\n    \"Valuation near historical averages suggests limited upside.\"\n  ],\n  \"key_drivers\": [\n    { \"driver\": \"Premium Growth\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n    { \"driver\": \"Underwriting Margin\", \"impact\": \"HIGH\", \"direction\": \"POS\" },\n    { \"driver\": \"Investment Income\", \"impact\": \"MED\", \"direction\": \"POS\" },\n    { \"driver\": \"Economic Conditions\", \"impact\": \"HIGH\", \"direction\": \"NEG\" },\n    { \"driver\": \"Regulatory Environment\", \"impact\": \"LOW\", \"direction\": \"NEG\" },\n    { \"driver\": \"Dividend Stability\", \"impact\": \"MED\", \"direction\": \"POS\" },\n    { \"driver\": \"Market Share\", \"impact\": \"MED\", \"direction\": \"POS\" },\n    { \"driver\": \"Cost Control\", \"impact\": \"MED\", \"direction\": \"POS\" }\n  ],\n  \"risks\": [\n    \"Further decline in premium revenues.\",\n    \"Increase in claims frequency or severity.\",\n    \"Interest rate volatility affecting investment income.\",\n    \"Regulatory changes impacting insurance products.\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 0.005,\n    \"ebit_margin_target\": 0.20,\n    \"wacc\": 0.055,\n    \"terminal_multiple\": 16\n  },\n  \"scenarios\": {\n    \"bear\": { \"target_price\": 105, \"prob\": 0.3, \"notes\": \"Prolonged revenue decline and lower multiples.\" },\n    \"base\": { \"target_price\": 115, \"prob\": 0.4, \"notes\": \"Stable performance with modest growth.\" },\n    \"bull\": { \"target_price\": 125, \"prob\": 0.3, \"notes\": \"Recovery in growth and improved margins.\" }\n  },\n  \"method_notes\": \"Valuation based on P/E multiples and DCF with insurer-specific assumptions. HOLD due to limited upside and mixed growth signals. Not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "Insurance_DCF_Multiples",
          "risks": [
            "Further decline in premium revenues.",
            "Increase in claims frequency or severity.",
            "Interest rate volatility affecting investment income.",
            "Regulatory changes impacting insurance products."
          ],
          "ticker": "AFL",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.4,
              "notes": "Stable performance with modest growth.",
              "target_price": 115
            },
            "bear": {
              "prob": 0.3,
              "notes": "Prolonged revenue decline and lower multiples.",
              "target_price": 105
            },
            "bull": {
              "prob": 0.3,
              "notes": "Recovery in growth and improved margins.",
              "target_price": 125
            }
          },
          "confidence": 0.6,
          "assumptions": {
            "wacc": 0.055,
            "revenue_cagr_3y": 0.005,
            "terminal_multiple": 16,
            "ebit_margin_target": 0.2
          },
          "key_drivers": [
            {
              "driver": "Premium Growth",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Underwriting Margin",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Investment Income",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Economic Conditions",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Regulatory Environment",
              "impact": "LOW",
              "direction": "NEG"
            },
            {
              "driver": "Dividend Stability",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Market Share",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Cost Control",
              "impact": "MED",
              "direction": "POS"
            }
          ],
          "method_notes": "Valuation based on P/E multiples and DCF with insurer-specific assumptions. HOLD due to limited upside and mixed growth signals. Not investment advice.",
          "current_price": 113,
          "recommendation": "HOLD",
          "thesis_bullets": [
            "Stable demand for supplemental insurance products.",
            "Recent negative revenue and EPS growth due to headwinds.",
            "Strong balance sheet with low debt enhances resilience.",
            "Dividend yield provides income but growth is uncertain.",
            "Valuation near historical averages suggests limited upside."
          ],
          "target_price_6m": 114,
          "target_price_12m": 115
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "endpoint": "https://api.deepseek.com/v1/chat/completions",
            "provider": "deepseek",
            "webSearch": {
              "enabled": false,
              "supported": false
            },
            "responseFormat": "json_object"
          },
          "sanityIssues": []
        },
        "latencyMs": 483,
        "createdAt": "2026-04-09T05:06:15.762Z",
        "usage": {
          "inputTokens": 2105,
          "outputTokens": 3793,
          "costUsd": 0.002182
        }
      },
      {
        "id": "cmnr0l45z01pdp658exxnt4v5",
        "runId": "cmnr0l45x01pap658lqttxmnl",
        "modelId": "gemini.3-pro",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"AFL_Equity_Model_v1\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"AFL\",\n  \"currency\": \"USD\",\n  \"current_price\": 113,\n  \"target_price_6m\": 114,\n  \"target_price_12m\": 116,\n  \"recommendation\": \"HOLD\",\n  \"confidence\": 0.7,\n  \"thesis_bullets\": [\n    \"Defensive business model with strong market position in US and Japan supplemental health insurance.\",\n    \"Near-term growth pressured by weak Yen and normalization of post-pandemic benefit ratios.\",\n    \"Valuation at 16x P/E and 2x P/B appears full given recent revenue contraction.\",\n    \"Exceptional balance sheet with minimal debt supports consistent dividend growth and share repurchases.\",\n    \"Wait for a better entry point or stabilization in Japan sales before upgrading.\"\n  ],\n  \"key_drivers\": [\n    {\n      \"driver\": \"USD/JPY exchange rate\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Japan postal network sales recovery\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"US earned premium growth\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Benefit ratio normalization\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Share repurchase program\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Investment portfolio yield\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    }\n  ],\n  \"risks\": [\n    \"Continued weakness in the Japanese Yen impacting translated earnings.\",\n    \"Slower than expected recovery in Japan face-to-face sales channels.\",\n    \"Higher than expected benefit ratios in US or Japan segments.\",\n    \"Regulatory changes in supplemental health insurance markets.\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 0.02,\n    \"ebit_margin_target\": 0.2,\n    \"wacc\": 0.075,\n    \"terminal_multiple\": 14.0\n  },\n  \"scenarios\": {\n    \"bear\": {\n      \"target_price\": 95,\n      \"prob\": 0.25,\n      \"notes\": \"Persistent Yen weakness and stagnant Japan sales compress multiples.\"\n    },\n    \"base\": {\n      \"target_price\": 116,\n      \"prob\": 0.55,\n      \"notes\": \"Modest premium growth and steady buybacks offset FX headwinds.\"\n    },\n    \"bull\": {\n      \"target_price\": 135,\n      \"prob\": 0.2,\n      \"notes\": \"Strong Yen recovery and robust US sales growth drive earnings beat.\"\n    }\n  },\n  \"method_notes\": \"Valuation based on a blend of historical P/E (14-15x) and DDM. Target implies ~15.5x forward EPS. Recommendation is HOLD due to limited upside (+2.6%) and FX headwinds. Not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AFL_Equity_Model_v1",
          "risks": [
            "Continued weakness in the Japanese Yen impacting translated earnings.",
            "Slower than expected recovery in Japan face-to-face sales channels.",
            "Higher than expected benefit ratios in US or Japan segments.",
            "Regulatory changes in supplemental health insurance markets."
          ],
          "ticker": "AFL",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.55,
              "notes": "Modest premium growth and steady buybacks offset FX headwinds.",
              "target_price": 116
            },
            "bear": {
              "prob": 0.25,
              "notes": "Persistent Yen weakness and stagnant Japan sales compress multiples.",
              "target_price": 95
            },
            "bull": {
              "prob": 0.2,
              "notes": "Strong Yen recovery and robust US sales growth drive earnings beat.",
              "target_price": 135
            }
          },
          "confidence": 0.7,
          "assumptions": {
            "wacc": 0.075,
            "revenue_cagr_3y": 0.02,
            "terminal_multiple": 14,
            "ebit_margin_target": 0.2
          },
          "key_drivers": [
            {
              "driver": "USD/JPY exchange rate",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Japan postal network sales recovery",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "US earned premium growth",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Benefit ratio normalization",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Share repurchase program",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Investment portfolio yield",
              "impact": "MED",
              "direction": "POS"
            }
          ],
          "method_notes": "Valuation based on a blend of historical P/E (14-15x) and DDM. Target implies ~15.5x forward EPS. Recommendation is HOLD due to limited upside (+2.6%) and FX headwinds. Not investment advice.",
          "current_price": 113,
          "recommendation": "HOLD",
          "thesis_bullets": [
            "Defensive business model with strong market position in US and Japan supplemental health insurance.",
            "Near-term growth pressured by weak Yen and normalization of post-pandemic benefit ratios.",
            "Valuation at 16x P/E and 2x P/B appears full given recent revenue contraction.",
            "Exceptional balance sheet with minimal debt supports consistent dividend growth and share repurchases.",
            "Wait for a better entry point or stabilization in Japan sales before upgrading."
          ],
          "target_price_6m": 114,
          "target_price_12m": 116
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "model": "gemini-3-pro-preview",
            "provider": "gemini",
            "webSearch": {
              "used": false,
              "allowed": false,
              "enabled": false,
              "requested": false,
              "disabledReason": null
            }
          },
          "sanityIssues": []
        },
        "latencyMs": 20702,
        "createdAt": "2026-04-09T05:06:15.762Z",
        "usage": {
          "inputTokens": 2412,
          "outputTokens": 804,
          "costUsd": 0.014472
        }
      },
      {
        "id": "cmnr0l45z01pbp658fcxujxqw",
        "runId": "cmnr0l45x01pap658lqttxmnl",
        "modelId": "openai.gpt-5.4",
        "status": "SUCCESS",
        "rawOutput": "{\"model\":\"AI Model Recommendation v2\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"AFL\",\"currency\":\"USD\",\"current_price\":113,\"target_price_6m\":115,\"target_price_12m\":117,\"recommendation\":\"HOLD\",\"confidence\":0.66,\"thesis_bullets\":[\"Strong balance sheet and low leverage support capital return.\",\"Consistent buybacks and dividend lift per-share value.\",\"Higher reinvestment yields aid medium-term earnings power.\",\"Japan and FX exposure can mute reported growth.\",\"Valuation looks near fair value after recent outperformance.\"],\"key_drivers\":[{\"driver\":\"Higher portfolio reinvestment yields\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Share repurchases\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Dividend growth\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Japan premium trends\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"USD/JPY translation\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Benefit ratio normalization\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Equity market volatility\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Richer valuation multiple\",\"impact\":\"MED\",\"direction\":\"NEG\"}],\"risks\":[\"Yen weakness pressures reported earnings.\",\"Benefit claims or persistency worsen.\",\"Rate declines compress investment income.\",\"Regulatory or product changes in Japan/U.S.\",\"Valuation de-rates despite stable operations.\"],\"assumptions\":{\"revenue_cagr_3y\":0.03,\"ebit_margin_target\":0.21,\"wacc\":0.085,\"terminal_multiple\":15.5},\"scenarios\":{\"bear\":{\"target_price\":99,\"prob\":0.25,\"notes\":\"FX headwinds and softer sales drive a modest de-rating.\"},\"base\":{\"target_price\":117,\"prob\":0.5,\"notes\":\"Steady underwriting, buybacks, and reinvestment gains keep value near fair.\"},\"bull\":{\"target_price\":132,\"prob\":0.25,\"notes\":\"Better Japan growth and favorable rates support higher EPS and multiple.\"}},\"method_notes\":\"Base case uses normalized earnings-power with a 15.5x terminal multiple, cross-checked to P/B and capital return. Snapshot fields were kept authoritative; no sell-side price targets used. HOLD matches ~3.5% 12M upside and mixed growth/FX signals; not investment advice.\"}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AI Model Recommendation v2",
          "risks": [
            "Yen weakness pressures reported earnings.",
            "Benefit claims or persistency worsen.",
            "Rate declines compress investment income.",
            "Regulatory or product changes in Japan/U.S.",
            "Valuation de-rates despite stable operations."
          ],
          "ticker": "AFL",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.5,
              "notes": "Steady underwriting, buybacks, and reinvestment gains keep value near fair.",
              "target_price": 117
            },
            "bear": {
              "prob": 0.25,
              "notes": "FX headwinds and softer sales drive a modest de-rating.",
              "target_price": 99
            },
            "bull": {
              "prob": 0.25,
              "notes": "Better Japan growth and favorable rates support higher EPS and multiple.",
              "target_price": 132
            }
          },
          "confidence": 0.66,
          "assumptions": {
            "wacc": 0.085,
            "revenue_cagr_3y": 0.03,
            "terminal_multiple": 15.5,
            "ebit_margin_target": 0.21
          },
          "key_drivers": [
            {
              "driver": "Higher portfolio reinvestment yields",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Share repurchases",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Dividend growth",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Japan premium trends",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "USD/JPY translation",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "Benefit ratio normalization",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Equity market volatility",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Richer valuation multiple",
              "impact": "MED",
              "direction": "NEG"
            }
          ],
          "method_notes": "Base case uses normalized earnings-power with a 15.5x terminal multiple, cross-checked to P/B and capital return. Snapshot fields were kept authoritative; no sell-side price targets used. HOLD matches ~3.5% 12M upside and mixed growth/FX signals; not investment advice.",
          "current_price": 113,
          "recommendation": "HOLD",
          "thesis_bullets": [
            "Strong balance sheet and low leverage support capital return.",
            "Consistent buybacks and dividend lift per-share value.",
            "Higher reinvestment yields aid medium-term earnings power.",
            "Japan and FX exposure can mute reported growth.",
            "Valuation looks near fair value after recent outperformance."
          ],
          "target_price_6m": 115,
          "target_price_12m": 117
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "openai",
            "webSearch": {
              "used": false,
              "enabled": false,
              "sources": [],
              "maxToolCalls": 2
            },
            "responseId": "resp_0c66037454f19cfd0069d73528074c8193917a7a2d3d7039a3",
            "reasoningEffort": "medium",
            "structuredOutputs": {
              "used": true,
              "requested": true,
              "disabledReason": null
            }
          },
          "sanityIssues": []
        },
        "latencyMs": 23273,
        "createdAt": "2026-04-09T05:06:15.762Z",
        "usage": {
          "inputTokens": 2376,
          "outputTokens": 1400,
          "costUsd": 0.023758
        }
      },
      {
        "id": "cmnr0l45z01pep658isxy3eug",
        "runId": "cmnr0l45x01pap658lqttxmnl",
        "modelId": "xai.grok-4.20-reasoning",
        "status": "SUCCESS",
        "rawOutput": "{\n  \"model\": \"AI Equity Analyst\",\n  \"as_of\": \"2026-04-08T20:00:02.000Z\",\n  \"ticker\": \"AFL\",\n  \"currency\": \"USD\",\n  \"current_price\": 113,\n  \"target_price_6m\": 119,\n  \"target_price_12m\": 126,\n  \"recommendation\": \"BUY\",\n  \"confidence\": 0.62,\n  \"thesis_bullets\": [\n    \"Stable supplemental insurance demand in aging populations\",\n    \"Strong Japan operations and cash flow support dividends\",\n    \"Negative YOY revenue growth signals market challenges\",\n    \"Low leverage balance sheet provides resilience\",\n    \"16x P/E offers moderate upside from base case\"\n  ],\n  \"key_drivers\": [\n    {\n      \"driver\": \"Aging population demand\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Japan earnings contribution\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Investment income yields\",\n      \"impact\": \"MED\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Premium revenue growth\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"POS\"\n    },\n    {\n      \"driver\": \"Yen currency volatility\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Regulatory changes\",\n      \"impact\": \"HIGH\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"US competitive pressure\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    },\n    {\n      \"driver\": \"Economic slowdown effects\",\n      \"impact\": \"MED\",\n      \"direction\": \"NEG\"\n    }\n  ],\n  \"risks\": [\n    \"Currency fluctuations in Japan\",\n    \"Lower investment yields\",\n    \"Increased industry competition\",\n    \"Regulatory healthcare shifts\",\n    \"Policy lapse from recession\"\n  ],\n  \"assumptions\": {\n    \"revenue_cagr_3y\": 3.5,\n    \"ebit_margin_target\": 0.21,\n    \"wacc\": 0.09,\n    \"terminal_multiple\": 15\n  },\n  \"scenarios\": {\n    \"bear\": {\n      \"target_price\": 98,\n      \"prob\": 0.25,\n      \"notes\": \"Stagnant growth and margin compression persist.\"\n    },\n    \"base\": {\n      \"target_price\": 126,\n      \"prob\": 0.5,\n      \"notes\": \"Stable operations and consistent dividends continue.\"\n    },\n    \"bull\": {\n      \"target_price\": 150,\n      \"prob\": 0.25,\n      \"notes\": \"Accelerated growth from new products and markets.\"\n    }\n  },\n  \"method_notes\": \"Hybrid DCF (revenue CAGR, EBIT margin, 9% WACC, 15x terminal) and P/E comps. 11% base upside supports BUY. not investment advice.\"\n}",
        "parsedJson": {
          "as_of": "2026-04-08T20:00:02.000Z",
          "model": "AI Equity Analyst",
          "risks": [
            "Currency fluctuations in Japan",
            "Lower investment yields",
            "Increased industry competition",
            "Regulatory healthcare shifts",
            "Policy lapse from recession"
          ],
          "ticker": "AFL",
          "currency": "USD",
          "scenarios": {
            "base": {
              "prob": 0.5,
              "notes": "Stable operations and consistent dividends continue.",
              "target_price": 126
            },
            "bear": {
              "prob": 0.25,
              "notes": "Stagnant growth and margin compression persist.",
              "target_price": 98
            },
            "bull": {
              "prob": 0.25,
              "notes": "Accelerated growth from new products and markets.",
              "target_price": 150
            }
          },
          "confidence": 0.62,
          "assumptions": {
            "wacc": 0.09,
            "revenue_cagr_3y": 3.5,
            "terminal_multiple": 15,
            "ebit_margin_target": 0.21
          },
          "key_drivers": [
            {
              "driver": "Aging population demand",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Japan earnings contribution",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Investment income yields",
              "impact": "MED",
              "direction": "POS"
            },
            {
              "driver": "Premium revenue growth",
              "impact": "HIGH",
              "direction": "POS"
            },
            {
              "driver": "Yen currency volatility",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Regulatory changes",
              "impact": "HIGH",
              "direction": "NEG"
            },
            {
              "driver": "US competitive pressure",
              "impact": "MED",
              "direction": "NEG"
            },
            {
              "driver": "Economic slowdown effects",
              "impact": "MED",
              "direction": "NEG"
            }
          ],
          "method_notes": "Hybrid DCF (revenue CAGR, EBIT margin, 9% WACC, 15x terminal) and P/E comps. 11% base upside supports BUY. not investment advice.",
          "current_price": 113,
          "recommendation": "BUY",
          "thesis_bullets": [
            "Stable supplemental insurance demand in aging populations",
            "Strong Japan operations and cash flow support dividends",
            "Negative YOY revenue growth signals market challenges",
            "Low leverage balance sheet provides resilience",
            "16x P/E offers moderate upside from base case"
          ],
          "target_price_6m": 119,
          "target_price_12m": 126
        },
        "errorsJson": {
          "attempts": [],
          "providerMeta": {
            "provider": "xai",
            "webSearch": {
              "used": false,
              "enabled": false,
              "sources": [],
              "maxToolCalls": 2
            },
            "responseId": "803e469a-dbe5-90c0-9922-0ff36786f5c7",
            "usedFallbackChatCompletions": false
          },
          "sanityIssues": []
        },
        "latencyMs": 20688,
        "createdAt": "2026-04-09T05:06:15.762Z",
        "usage": {
          "inputTokens": 2717,
          "outputTokens": 3141,
          "costUsd": 0.055266
        }
      }
    ]
  }
}